Dosage prescribed is determined by the licensed provider based on medical judgment.
GLP-1/GIP (glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide) receptor agonists are advanced, hormone-based medications originally designed to improve blood sugar control in people with type 2 diabetes. By mimicking the actions of these natural incretin hormones, they stimulate insulin secretion when glucose levels are elevated, reduce excess glucagon release, and slow gastric emptying to stabilize post-meal blood sugar. Beyond glycemic benefits, GLP-1/GIP therapies also act on the brain’s appetite-regulating pathways, enhancing satiety and lowering caloric intake, which supports meaningful weight loss. This dual mechanism makes GLP-1/GIP not only an effective treatment for type 2 diabetes but also a scientifically validated option for long-term weight management and metabolic health.
GLP-1/GIP + B12 is used to treat type 2 diabetes. It is prescribed alongside diet and exercise to help control blood sugar levels. GLP-1/GIP + B12 acts as a glucagon-like peptide-1 (GLP-1) receptor agonist with added benefits from GIP and B12.
GLP-1/GIP + B12 is also used to support weight loss and long-term weight management in patients with obesity related to certain medical conditions.
This medication is available only with a valid prescription from your healthcare provider.
WHY IT MATTERS
Improves blood sugar and reduces insulin by increasing glucose uptake
Its ability to reduce insulin, a fat storage hormone, can also support weight loss
Associated with reduced risk of cancer, cardiovascular disease, and neurodegenerative disease
By reducing chronic disease risk, metformin has been linked to increased longevity
